Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Quintiles Names Head of Clinical, Data Ops | Contract Pharma

What are you searching for?

Sign in
Breaking News

Quintiles Names Head of Clinical, Data Ops

Skolsky to lead clinical division to monitor conduct, collect data

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Steven Skolsky has been appointed global head of Quintiles Clinical & Data Operations (CDO) unit in the Clinical Development division. This division monitors the clinical conduct at research sites and collects and manages data from patients in hundreds of clinical trials conducted around the world.
 
Mr. Skolsky will lead the 5,000-employee CDO unit, which unites Clinical Data Management and Clinical Operations in an effort to accelerate data flow and ensure the quality of data.

“Steve’s deep knowledge of the industry and proven leadership capabilities will enable Quintiles to increase the value that we deliver to customers in today’s rapidly changing environment we call the New Health,” said Paula Brown Stafford, president of Clinical Development at Quintiles.

Mr. Skolsky previously served as vice chairman of the board and is a current board director for Basilea Pharmaceutica. He also serves as a member of the board of directors for Adherex Technologies, a clinical stage oncology company based in Raleigh, NC. Most recently, he was principal at Expis Partners, a strategic life science consultancy.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics